Saladax, Ilex Medical Ink Distribution Deal for Israel | GenomeWeb

NEW YORK (GenomeWeb News) – Saladax Biomedical today announced Ilex Medical will exclusively distribute three of its tests in Israel.

Under the agreement, Ilex will distribute My5-FU, MyPaclitaxel, and MyDocetaxel diagnostic reagent kits, which are designed to measure the level of the chemotherapy drugs in blood "to overcome the limitations associated with dosing based on body surface area," or BSA, Saladax said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: CRISPR-based barcodes to trace cell lineages, and more.

The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.

French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.